157 related articles for article (PubMed ID: 30257369)
1. Pharmacological insights into antioxidants against colorectal cancer: A detailed review of the possible mechanisms.
Gothai S; Muniandy K; Gnanaraj C; Ibrahim IAA; Shahzad N; Al-Ghamdi SS; Ayoub N; Veeraraghavan VP; Kumar SS; Esa NM; Arulselvan P
Biomed Pharmacother; 2018 Nov; 107():1514-1522. PubMed ID: 30257369
[TBL] [Abstract][Full Text] [Related]
2. Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.
Yashiro M
Dig Dis Sci; 2015 Aug; 60(8):2251-63. PubMed ID: 25840920
[TBL] [Abstract][Full Text] [Related]
3. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and colorectal cancer.
Kraus S; Arber N
Curr Opin Pharmacol; 2009 Aug; 9(4):405-10. PubMed ID: 19589728
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
6. [Colitis-associated colorectal carcinoma: epidemiology, pathogenesis and early diagnosis].
Scharl M; Biedermann L; Rogler G
Praxis (Bern 1994); 2014 Jan; 103(3):149-54. PubMed ID: 24468454
[TBL] [Abstract][Full Text] [Related]
7. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species in colorectal cancer: The therapeutic impact and its potential roles in tumor progression via perturbation of cellular and physiological dysregulated pathways.
Moradi-Marjaneh R; Hassanian SM; Mehramiz M; Rezayi M; Ferns GA; Khazaei M; Avan A
J Cell Physiol; 2019 Jul; 234(7):10072-10079. PubMed ID: 30515827
[TBL] [Abstract][Full Text] [Related]
9. Colorectal Carcinogenesis: Role of Oxidative Stress and Antioxidants.
Carini F; Mazzola M; Rappa F; Jurjus A; Geagea AG; Al Kattar S; Bou-Assi T; Jurjus R; Damiani P; Leone A; Tomasello G
Anticancer Res; 2017 Sep; 37(9):4759-4766. PubMed ID: 28870894
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational and Transformational Risks Posed by Exogenous Free Hemoglobin Alpha Chain, A By-Product of Extravasated Erythrocyte Macrophage Erythrophagocytosis.
Bragg MA; Breaux WA; M'Koma AE
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37476546
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress in ulcerative colitis-associated carcinogenesis.
Roessner A; Kuester D; Malfertheiner P; Schneider-Stock R
Pathol Res Pract; 2008; 204(7):511-24. PubMed ID: 18571874
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
Herszényi L; Barabás L; Miheller P; Tulassay Z
Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
[TBL] [Abstract][Full Text] [Related]
13. Chemoprevention with phytonutrients and microalgae products in chronic inflammation and colon cancer.
Talero E; Ávila-Roman J; Motilva V
Curr Pharm Des; 2012; 18(26):3939-65. PubMed ID: 22632755
[TBL] [Abstract][Full Text] [Related]
14. Comparison of in vitro tests for antioxidant and immunomodulatory capacities of compounds.
Becker K; Schroecksnadel S; Gostner J; Zaknun C; Schennach H; Uberall F; Fuchs D
Phytomedicine; 2014 Jan; 21(2):164-71. PubMed ID: 24041614
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of Huangqin Decoction against ulcerative colitis and associated cancer in mice.
Chen G; Yang Y; Hu C; Cheng X; Xu Y; Cai X; Wang M; Yang CS; Cao P
Oncotarget; 2016 Sep; 7(38):61643-61655. PubMed ID: 27557503
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention for colon cancer: new opportunities, fact or fiction?
Terhaar Sive Droste JS; Tuynman JB; Van Dullemen HM; Mulder CJ
Scand J Gastroenterol Suppl; 2006; (243):158-64. PubMed ID: 16782636
[TBL] [Abstract][Full Text] [Related]
17. The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models.
Balmus IM; Ciobica A; Trifan A; Stanciu C
Saudi J Gastroenterol; 2016; 22(1):3-17. PubMed ID: 26831601
[TBL] [Abstract][Full Text] [Related]
18. Oxidative and antioxidative mechanisms in oral cancer and precancer: a review.
Choudhari SK; Chaudhary M; Gadbail AR; Sharma A; Tekade S
Oral Oncol; 2014 Jan; 50(1):10-8. PubMed ID: 24126222
[TBL] [Abstract][Full Text] [Related]
19. Oxidative Stress and Antioxidant Potential of One Hundred Medicinal Plants.
Hassan W; Noreen H; Rehman S; Gul S; Kamal MA; Kamdem JP; Zaman B; da Rocha JBT
Curr Top Med Chem; 2017; 17(12):1336-1370. PubMed ID: 28049396
[TBL] [Abstract][Full Text] [Related]
20. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.
Fornaro R; Caratto M; Caratto E; Caristo G; Fornaro F; Giovinazzo D; Sticchi C; Casaccia M; Andorno E
Clin Colorectal Cancer; 2016 Sep; 15(3):204-12. PubMed ID: 27083409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
